Patent · US Active

Protein expression system

US8674084B2 · kind B2 · utility

10Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 8, 2009
Grant dateMar 18, 2014
Priority date
Expiry dateMar 21, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/8258
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The inventions is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (‘CPMV-HT’) based protein expression system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.